hotspot -WSS

hotspot

author：leisure time 2025-09-30 18:59:30 - browse：42

Vivistim and Lead — A small Texas company is testing whether pairing vagus nerve stimulation with rehabilitation exercise can restore movement in people who have had a stroke. STAT/MicroTransponder, Inc.

Despite being forced by Hurricane Irma to close its outpatient facilities for several days, the Mayo Clinic in Jacksonville, Fla., is expected to forge ahead this month with a pivotal clinical trial testing whether an electrical implant can rewire the brains of stroke patients so they can use their arms and hands again.

If the patients who receive implants regain significantly more function than those who get only standard rehabilitation, it will show that stroke-damaged brain circuits can be bypassed like shorts in a circuit board, with healthy neurons coaxed into performing the job of those fried by stroke.

Although the results might not be make-or-break for the little 11-year-old Texas company sponsoring the trial (called MicroTransponder, the company’s also testing whether an electrical implant can alleviate tinnitus), there will be more evidence of whether “electroceuticals” — electrical stimuli tailored to treat diseases — work beyond their current use in controlling pain and a few other conditions or will fall short of the buzz surrounding them.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： What do new weight loss drugs mean for bariatric surgery?

Wikipedia

WSS

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

Appeals court upholds limits to abortion pill

CDC advisory panel says seniors 'may' get RSV vaccine

Bernie Sanders is gearing up to subpoena pharma CEOs

Medicare Advantage insurers face 0.2% cut to 2025 payments

Departing Stanford president retracts two papers

leisure time

hotspot

hotspot

At least 13 dead in Texas as scorching temps continue

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

Supreme Court strikes down use of affirmative action

What do new weight loss drugs mean for bariatric surgery?

Jerome Adams on the need for new antivirals for Covid

New clues to why women have higher risk of autoimmune disorders

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Diversity in medical illustrations gets boost from Chidiebere Ibe

The high cost of giving birth even with insurance

How to make Best Hospitals ratings actually useful for patients

hotspot

Neuroscience startup Neumora files for IPO

AstraZeneca bets AAV gene therapy will still deliver the goods

Investment in vaccine development is lagging, report finds

Why you shouldn’t ask, “What country has the best health care?”

In science, is the line between industry and academia shifting?

AstraZeneca bets AAV gene therapy will still deliver the goods

focus

focus

Wikipedia

focus